Wodstab Tablet contains Fexofenadine 120 mg, a second-generation antihistamine used primarily for the relief of allergic symptoms. Fexofenadine acts as a selective peripheral H1-receptor antagonist, effectively reducing the effects of histamine, a substance responsible for allergy manifestations such as sneezing, nasal congestion, runny nose, and itchy or watery eyes. Wodstab Tablet is indicated for the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria, providing symptomatic relief without causing significant sedation due to its limited penetration of the blood-brain barrier. The 120 mg dosage is typically administered once daily, ensuring convenient dosing and improved patient compliance. Wodstab is well tolerated, with a favorable safety profile; common adverse effects may include headache, drowsiness, and dry mouth, though these are generally mild and transient. It is contraindicated in patients with known hypersensitivity to Fexofenadine or any of its excipients. Caution is advised in individuals with renal impairment, and dose adjustment may be necessary. Wodstab Tablet should be used under medical supervision, particularly in pregnant or lactating women, and in patients taking other medications to avoid potential drug interactions. Overall, Wodstab Tablet offers effective, non-sedating relief for allergic conditions, enhancing patient quality of life.